miércoles, 4 de octubre de 2023
New FDA OWH resources for Breast Cancer Awareness Month
https://www.fda.gov/consumers/womens-health-topics/mammography?utm_medium=email&utm_source=govdelivery
What Does It Mean to Have Dense Breasts?What Does It Mean to Have Dense Breasts?
https://www.cdc.gov/cancer/breast/basic_info/dense-breasts.htm?utm_medium=email&utm_source=govdelivery
Pink Ribbon Guide - Mammography MattersPink Ribbon Guide - Mammography Matters
https://www.fda.gov/consumers/take-time-care-program/pink-ribbon-guide-mammography-matters?utm_medium=email&utm_source=govdelivery
FDA Authorizes Updated Novavax COVID-19 Vaccine Formulated to Better Protect Against Currently Circulating Variants
https://www.fda.gov/news-events/press-announcements/fda-authorizes-updated-novavax-covid-19-vaccine-formulated-better-protect-against-currently?utm_medium=email&utm_source=govdelivery
Today, the U.S. Food and Drug Administration amended the emergency use authorization (EUA) of the Novavax COVID-19 Vaccine, Adjuvanted for use in individuals 12 years of age and older to include the 2023-2024 formula. Individuals 12 years of age and older previously vaccinated with a COVID-19 vaccine (and who have not already been vaccinated with a recently updated mRNA COVID-19 vaccine) are eligible to receive one dose and unvaccinated individuals receive two doses.
The updated vaccine addresses currently circulating variants to provide better protection against serious consequences of COVID-19, including hospitalization and death. Consistent with the totality of the evidence and input from the FDA’s expert advisors, the Novavax COVID-19 Vaccine, Adjuvanted, a monovalent vaccine, has been updated to include the spike protein from the SARS-CoV-2 omicron variant lineage XBB.1.5 (2023-2024 formula).
This authorization follows the FDA’s recent approvals and authorizations of updated mRNA COVID-19 vaccines for 2023-2024 manufactured by ModernaTX Inc. and Pfizer Inc.
“The COVID-19 vaccines have saved countless lives and have prevented serious outcomes of COVID-19 caused by the SARS-CoV-2 virus,” said Peter Marks, M.D., Ph.D., director of the FDA’s Center for Biologics Evaluation and Research. “Today’s authorization provides an additional COVID-19 vaccine option that meets the FDA’s standards for safety, effectiveness and manufacturing quality needed to support emergency use authorization. As we head into the fall season and transition into 2024, we strongly encourage those who are eligible to consider receiving an updated COVID-19 vaccine to provide better protection against currently circulating variants.”
The FDA evaluated manufacturing data to support the change to the 2023-2024 formula of the Novavax COVID-19 Vaccine, Adjuvanted. Additionally, the FDA evaluated non-clinical immune response data suggesting that the vaccine provides protection against the currently circulating COVID-19 variants. The agency also relied on its evaluation of safety and effectiveness data from clinical trials of Novavax COVID-19, Vaccine, Adjuvanted (Original monovalent) and investigational monovalent and bivalent Novavax COVID-19 adjuvanted vaccines, as well as postmarketing data. The data accrued with these Novavax COVID-19 vaccines are relevant to Novavax COVID-19 Vaccine, Adjuvanted (2023-2024 Formula) as the vaccines are manufactured using a similar process.
The FDA has determined that the Novavax COVID-19 Vaccine, Adjuvanted (2023-2024 Formula) has met the statutory criteria for issuance of an EUA, and that the known and potential benefits of the vaccine outweigh its known and potential risks in individuals 12 years of age and older.
Domestic Violence Awareness Month Portal
https://www.acf.hhs.gov/ofvps/domestic-violence-awareness-month-portal?utm_medium=email&utm_source=govdelivery
This October, we are celebrating the 39th Anniversary of the Family Violence Prevention and Services Act (FVPSA). For 39 years, FVPSA funding has been an integral part of our nation’s public health response to domestic violence by providing emergency shelters, crisis hotlines, prevention programs, resource centers, specialized services for children exposed to violence, and a wide range of federal, state, local, and tribal partners across the United States.
martes, 3 de octubre de 2023
Global HIV control: is the glass half empty or half full? Nachega et al.
https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(23)00150-9/fulltext
Efficacy, safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir for HIV pre-exposure prophylaxis in transgender women: a secondary analysis of the HPTN 083 trial
Marzinke et al.
https://www.thelancet.com/journals/lanhiv/home
Plasma Proteins Science Day November 9, 2023
https://www.siemens-healthineers.com/news-and-events/conferences-events-new/plasma-proteins-science-day
Join leading experts and hear about their experiences and learnings in the diagnosis and management of several challenging plasma protein-related disorders, including:
Diagnosis and management of IgG4-related disease
Diagnosis and management of monoclonal gammopathies of renal significance
Excluding intrathecal inflammation using the free light chain kappa quotient diagram
Serum free light chains testing in monoclonal gammopathies
Experts will present in English.
lunes, 2 de octubre de 2023
UK oncology approvals in 2022: global regulatory collaboration and new regulatory pathways deliver new anti-cancer therapies Lythgoe et al.
https://www.thelancet.com/journals/lanonc/home?dgcid=hubspot_email_jcr23_lanonc&utm_campaign=jcr23&utm_medium=email&_hsmi=272344974&_hsenc=p2ANqtz-8Xdk8h7-PNuDuZVNdgKn7v25D7LgComxZr0M33RqtmMi2fJtkAt_ErBCeJGQ6IdQrUiCkjsrjUV1JDWq_uqt8yeGurDA&utm_content=272344974&utm_source=hs_automation
Tumor Treating Fields therapy could potentiate immunotherapy in non-small-cell lung cancer
Dean A Fennell
https://www.thelancet.com/journals/lanonc/issue/current
National Cancer Institute Collaborative Workshop on Shaping the Landscape of Brain Metastases Research: challenges and recommended priorities
https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(23)00297-8/fulltext?dgcid=hubspot_email_jcr23_lanonc&utm_campaign=jcr23&utm_medium=email&_hsmi=272344974&_hsenc=p2ANqtz-82V8fdsqrZWWQ7ijqnhiNAFkiXe0voL515TGrtWf73T3bngruy4-9cvWU2Sn_bHiX1ZXMEfwzzxGlx0-PYiyWpCyTwJw&utm_content=272344974&utm_source=hs_automation
Management of multiple myeloma-related renal impairment: recommendations from the International Myeloma Working Group
https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(23)00223-1/fulltext?dgcid=hubspot_email_jcr23_lanonc&utm_campaign=jcr23&utm_medium=email&_hsmi=272344974&_hsenc=p2ANqtz-8QWg5mgDQoqvKc3JLgBlp7wWSHaq_tlHcbcHukJI2RyvM_KiqCTjwZf9Kr0Ggyt2_ieNXUM83eRfZfWEQSJgMdGCiYYg&utm_content=272344974&utm_source=hs_automation
Current drug development and trial designs in neuro-oncology: report from the first American Society of Clinical Oncology and Society for Neuro-Oncology Clinical Trials Conference
https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(23)00005-0/fulltext?dgcid=hubspot_email_jcr23_lanonc&utm_campaign=jcr23&utm_medium=email&_hsmi=272344974&_hsenc=p2ANqtz--nah1RPKDMLe0p2Lo-Q1C_7foFWP9vZTyWQ3MGwQCG6vkAhPLMqqbtDJ46QSP93sL7DrpOyXIcdX_F7-A25NRg52Lk8A&utm_content=272344974&utm_source=hs_automation
Multinational Association of Supportive Care in Cancer (MASCC) clinical practice guidelines for the prevention and management of acute radiation dermatitis: international Delphi consensus-based recommendations
https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(23)00067-0/fulltext?dgcid=hubspot_email_jcr23_lanonc&utm_campaign=jcr23&utm_medium=email&_hsmi=272344974&_hsenc=p2ANqtz-_0_ryFvizI_hrMrz0aSTHqRwr6_XtdA0VDNxIij9ZEU8WXhftIuU7bY6ab3iHECAIMWWP_JvB7CpNQdX8XFU7-2ozRSw&utm_content=272344974&utm_source=hs_automation
Metastases-directed stereotactic body radiotherapy in combination with targeted therapy or immunotherapy: systematic review and consensus recommendations by the EORTC–ESTRO OligoCare consortium
https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(22)00752-5/fulltext?dgcid=hubspot_email_jcr23_lanonc&utm_campaign=jcr23&utm_medium=email&_hsmi=272344974&_hsenc=p2ANqtz--wJ-9GUaqmyEp5T6TQwVXpN3nEInKcgGcvPv2O3TPAR1-Kj7vAUCQASXIWsrkQ1I6roCAyVVHa438mRY-AXxElJLbn6g&utm_content=272344974&utm_source=hs_automation
Setting International Standards in Analyzing Patient-Reported Outcomes and Quality of Life Endpoints in Cancer Clinical Trials-Innovative Medicines Initiative (SISAQOL-IMI): stakeholder views, objectives, and procedures
https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(23)00157-2/fulltext?dgcid=hubspot_email_jcr23_lanonc&utm_campaign=jcr23&utm_medium=email&_hsmi=272344974&_hsenc=p2ANqtz-9Ego-FRZIPFyF7AQ7k-g6NjlNISAI1xCIP0K7VfkRGtd8zUYaVCNLOnHFuWfFRtpfO0WOXJuQTmSwMkRkTe7nBJi26zg&utm_content=272344974&utm_source=hs_automation
domingo, 1 de octubre de 2023
Effect of 13-valent pneumococcal conjugate vaccine on experimental carriage of Streptococcus pneumoniae serotype 6B in Blantyre, Malawi: a randomised controlled trial and controlled human infection study Dula et al.
https://www.thelancet.com/journals/lanmic/home?dgcid=hubspot_email_jcr23_lanmic&utm_campaign=jcr23&utm_medium=email&_hsmi=272344417&_hsenc=p2ANqtz--qyNVZ4PfB03pc6ln8BcuyVOFKPm-nlk6-nEZCV5F0IRnbzyVhW7GIwT3Kw2MsLBixDL9h9lEe1xLiU1WGRisTt7q1nw&utm_content=272344417&utm_source=hs_automation
Interference between rhinovirus and influenza A virus: a clinical data analysis and experimental infection study
https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(20)30114-2/fulltext?dgcid=hubspot_email_jcr23_lanmic&utm_campaign=jcr23&utm_medium=email&_hsmi=272344417&_hsenc=p2ANqtz-_mCJFbMe3SPbElg0N6CCD6X-9vnD1O9sqVG_d4VMm4fdeQaTQRrEL31CjBVGSHjxBBManvY1RmWG0BYsizYuOs1ytYLQ&utm_content=272344417&utm_source=hs_automation
The durability of immunity against reinfection by SARS-CoV-2: a comparative evolutionary study
https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(21)00219-6/fulltext?dgcid=hubspot_email_jcr23_lanmic&utm_campaign=jcr23&utm_medium=email&_hsmi=272344417&_hsenc=p2ANqtz-9MajtMEMAlQn1A36u6xsdvZDHikpcFpRMQoRRO4RzNsTE2rXosrrKguF8MQFqtWDvwS2JFj5VVAuUpZW3jQjC1MSZWcA&utm_content=272344417&utm_source=hs_automation
Epidemiological and molecular investigations of a point-source outbreak of Dracunculus medinensis infecting humans and dogs in Chad: a cross-sectional study
https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(21)00209-3/fulltext?dgcid=hubspot_email_jcr23_lanmic&utm_campaign=jcr23&utm_medium=email&_hsmi=272344417&_hsenc=p2ANqtz-8_3qqa5tITIF-0Oe018iACh5gH8bdH8Xah8UrkSRq10I3nOtFeHmBVu7W8_kWr7yBJqKpxhE6fxca29hend6SPpd0_hw&utm_content=272344417&utm_source=hs_automation
The 2021 WHO catalogue of Mycobacterium tuberculosis complex mutations associated with drug resistance: a genotypic analysis
https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(21)00301-3/fulltext?dgcid=hubspot_email_jcr23_lanmic&utm_campaign=jcr23&utm_medium=email&_hsmi=272344417&_hsenc=p2ANqtz--0QEy0l8UU7JmJTilWOG-2Hris6aXJtxpcAjPylQMbdpCK2GZR6Uxg0-B2XgmuSHkCZ8zAtPO1Y0m5HMGJKL9jTn4HDw&utm_content=272344417&utm_source=hs_automation
Monitoring monkeypox virus in saliva and air samples in Spain: a cross-sectional study
https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(22)00291-9/fulltext?dgcid=hubspot_email_jcr23_lanmic&utm_campaign=jcr23&utm_medium=email&_hsmi=272344417&_hsenc=p2ANqtz-_8qQ4yOCFCvmpTtrH59y0oNDWa8RB3qua1ycjFHOya5BZEKns4GGFl3ALioBhR9d1vEb_mqa4_UKq24_KWaMIFT6XxlA&utm_content=272344417&utm_source=hs_automation
Negative wealth shocks in later life and subsequent cognitive function in older adults in China, England, Mexico, and the USA, 2012–18: a population-based, cross-nationally harmonised, longitudinal study Cho et al.
https://www.thelancet.com/journals/lanhl/home?dgcid=hubspot_email_jcr23_lanhl&utm_campaign=jcr23&utm_medium=email&_hsmi=272342363&_hsenc=p2ANqtz-9n2G9ABKvlFQrckOxJWxK4wvmhsA3_CWdMzmU6grtR60x4BaEoVzDS4KVRtlHxm42dlcgr0WBXTYVDDb4pKgWG2hUTRw&utm_content=272342363&utm_source=hs_automation
Targeting the biology of ageing with mTOR inhibitors to improve immune function in older adults: phase 2b and phase 3 randomised trials
https://www.thelancet.com/journals/lanhl/article/PIIS2666-7568(21)00062-3/fulltext?dgcid=hubspot_email_jcr23_lanhl&utm_campaign=jcr23&utm_medium=email&_hsmi=272342363&_hsenc=p2ANqtz--9LSYCB5NHRLaBS9gOdZJWRPDicNde2vDvALrMcNrI9pv4ooKEwMeLklGoR06xA2o5J1snyT_Js-so-S8S8HoUaOH90g&utm_content=272342363&utm_source=hs_automation
Joint associations of physical activity and sleep duration with cognitive ageing: longitudinal analysis of an English cohort study
https://www.thelancet.com/journals/lanhl/article/PIIS2666-7568(23)00083-1/fulltext?dgcid=hubspot_email_jcr23_lanhl&utm_campaign=jcr23&utm_medium=email&_hsmi=272342363&_hsenc=p2ANqtz-9-6pZgjE0lsBaTDCbty2_mAgw1HmCRewwrnWfj9FGZXi-1pTDCkmY6AnLCY-C5Ef8iNh6oBiUBrOUEIJdtTLbjQC08ww&utm_content=272342363&utm_source=hs_automation
The state of diabetes treatment coverage in 55 low-income and middle-income countries: a cross-sectional study of nationally representative, individual-level data in 680 102 adults
https://www.thelancet.com/journals/lanhl/article/PIIS2666-7568(21)00089-1/fulltext?dgcid=hubspot_email_jcr23_lanhl&utm_campaign=jcr23&utm_medium=email&_hsmi=272342363&_hsenc=p2ANqtz--EcvicNY4uWdc7mNR8IoTz73u2AWeq4TwlbQeNA0-S9Qm1eF4eoNm1Rtov_RAVR4DYgB932gK1Bx0Z7bnWa-1fv-3jsA&utm_content=272342363&utm_source=hs_automation
Effects of physical exercise on physical function in older adults in residential care: a systematic review and network meta-analysis of randomised controlled trials
https://www.thelancet.com/journals/lanhl/article/PIIS2666-7568(23)00057-0/fulltext?dgcid=hubspot_email_jcr23_lanhl&utm_campaign=jcr23&utm_medium=email&_hsmi=272342363&_hsenc=p2ANqtz-8R2nWgbxbx9NgLp6hcreIHQcPSuoALjcC_zqZv5x9YeypTW3xerLcf5EbZZ3LzN139PfGF7yvY7u75_eoFHDXNHWOTNA&utm_content=272342363&utm_source=hs_automation
Effects of incorporating multidomain interventions into integrated primary care on quality of life: a randomised controlled trial
https://www.thelancet.com/journals/lanhl/article/PIIS2666-7568(21)00248-8/fulltext?dgcid=hubspot_email_jcr23_lanhl&utm_campaign=jcr23&utm_medium=email&_hsmi=272342363&_hsenc=p2ANqtz-_P9Ul8LAtvWXryXt_1yVfFZgpZcwjnC1atP7ZLVTo1FJBBc8J8QvDHQXvCVDJIWnj4LZQXwnF9A8OaM2IhHu3QvN1D-w&utm_content=272342363&utm_source=hs_automation
Tackling the enormous global burden of anaemia The Lancet Haematology
https://www.thelancet.com/journals/lanhae/home?dgcid=hubspot_email_jcr23_lanhae&utm_campaign=jcr23&utm_medium=email&_hsmi=272339749&_hsenc=p2ANqtz-9UNhgUP3ln5jSUkU0IJ8DLeGvYdz3AZewDITBHJ6yRYInyrbKypqaCjRL6yn8rXNJ14eLphQz8VB83yE1LGGkc_6KDSw&utm_content=272339749&utm_source=hs_automation
Defining global strategies to improve outcomes in sickle cell disease: a Lancet Haematology Commission
https://www.thelancet.com/commissions/sickle-cell-disease?dgcid=hubspot_email_jcr23_lanhae&utm_campaign=jcr23&utm_medium=email&_hsmi=272339749&_hsenc=p2ANqtz-_crY8AfrB3gaPdFyE8oCcNwDwVvklMrbOVLAM6CaJtowC-wNYAUhyLkc8EBA12HRl9Fhg8bZB36Q41NBb_VUZHLQ3A3w&utm_content=272339749&utm_source=hs_automation
Prevalence, years lived with disability, and trends in anaemia burden by severity and cause, 1990–2021: findings from the Global Burden of Disease Study 2021
Open Access
https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(23)00160-6/fulltext?dgcid=hubspot_email_jcr23_lanhae&utm_campaign=jcr23&utm_medium=email&_hsmi=272339749&_hsenc=p2ANqtz--dyn5MIuVa3qHweFBByHVBdRKy1CTQOxUWFPNCNsONQF1r1TtnJ6159RTUyOlPTmWz8yZwCKy7mRfbQUY1nOcTEb6cyg&utm_content=272339749&utm_source=hs_automation
Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000–2021: a systematic analysis from the Global Burden of Disease Study 2021
Open Access
https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(23)00118-7/fulltext?dgcid=hubspot_email_jcr23_lanhae&utm_campaign=jcr23&utm_medium=email&_hsmi=272339749&_hsenc=p2ANqtz-8tjc4D5rJHwZp1DR3gFwH-lGFGxqB0krMLCsjr7pR6J6dNGZ5hSKLqb9mc5jJqgM90LL89g-ffRa2WvIKkY4RL9c8U9Q&utm_content=272339749&utm_source=hs_automation
Resuscitation with blood products in patients with trauma-related haemorrhagic shock receiving prehospital care (RePHILL): a multicentre, open-label, randomised, controlled, phase 3 trial
Open Access
https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(22)00040-0/fulltext?dgcid=hubspot_email_jcr23_lanhae&utm_campaign=jcr23&utm_medium=email&_hsmi=272339749&_hsenc=p2ANqtz-8rMG9wO5J1BMLuSSMe8l9l1tvK7HoTQu9RGAABC1j2qiYWqhL4R-xE81AW0Jr1uB6ZliBNDsSa3fRnRDmZ8iZuaWmgGA&utm_content=272339749&utm_source=hs_automation
Odronextamab, a human CD20×CD3 bispecific antibody in patients with CD20-positive B-cell malignancies (ELM-1): results from the relapsed or refractory non-Hodgkin lymphoma cohort in a single-arm, multicentre, phase 1 trial
https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(22)00072-2/fulltext?dgcid=hubspot_email_jcr23_lanhae&utm_campaign=jcr23&utm_medium=email&_hsmi=272339749&_hsenc=p2ANqtz-8oJZaw7vC8aZKB2tIMzDyUC6SzM5tSf46RtR217fJMK4yZWWrcg5y_bvbUUk2VXG7iL81IkZpGPD9K9mIAMDSK3Jatqg&utm_content=272339749&utm_source=hs_automation
Safety and immunogenicity of a novel multivalent OspA-based vaccine candidate against Lyme borreliosis: a randomised, phase 1 study in healthy adults Bézay et al.
https://www.thelancet.com/journals/laninf/home?dgcid=hubspot_email_jcr23_laninf&utm_campaign=jcr23&utm_medium=email&_hsmi=272117798&_hsenc=p2ANqtz-_5Ng__dMfcHZ76AywuGGbgURalKjX-w99-WeVHAKyksY2nP0jPvx9MNxcnIPtipvmSfasN31BYZddFIMbddvnLlfDF3A&utm_content=272117798&utm_source=hs_automation
Oct 2023
Volume 23Number 10p1095-1206, e390-e454
Can we control dengue?
The Lancet Infectious Diseases
https://www.thelancet.com/journals/laninf/issue/current
Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind, parallel-group, phase 3 trial
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(23)00299-2/fulltext?dgcid=hubspot_email_jcr23_laninf&utm_campaign=jcr23&utm_medium=email&_hsmi=272117798&_hsenc=p2ANqtz--Hq965Me3GzdYMCHrCO9aWMFTaubeMh-Zbx2bwMlqDdU9BTQ4XXVynY5tPymlna4AWjzJvtaYg899AwPtlgTHIqizlwA&utm_content=272117798&utm_source=hs_automation
Clinical features and management of individuals admitted to hospital with monkeypox and associated complications across the UK: a retrospective cohort study
Open Access
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(22)00806-4/fulltext?dgcid=hubspot_email_jcr23_laninf&utm_campaign=jcr23&utm_medium=email&_hsmi=272117798&_hsenc=p2ANqtz-_zbHIafAX8N4A5k-vXWTLPYfhp6Ee4qm6jTMYJT69ucaihULbl9DFTIAa9UQiIWE6_oKFQfVcu-mm1QYHZ_4mLAaguAQ&utm_content=272117798&utm_source=hs_automation
Efficacy and safety of sulbactam–durlobactam versus colistin for the treatment of patients with serious infections caused by Acinetobacter baumannii–calcoaceticus complex: a multicentre, randomised, active-controlled, phase 3, non-inferiority clinical trial (ATTACK)
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(23)00184-6/fulltext?dgcid=hubspot_email_jcr23_laninf&utm_campaign=jcr23&utm_medium=email&_hsmi=272117798&_hsenc=p2ANqtz--ox9ZXXcdjaIRgYRl3us50Y1UFAf2V1cqvhFzWlIdYhk-GJFQtlfEES7fUTSXEecrp0oo3bl26HNCqoMdnA5WNqGz23w&utm_content=272117798&utm_source=hs_automation
Efficacy and immunogenicity of R21/Matrix-M vaccine against clinical malaria after 2 years' follow-up in children in Burkina Faso: a phase 1/2b randomised controlled trial
Open Access
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(22)00442-X/fulltext?dgcid=hubspot_email_jcr23_laninf&utm_campaign=jcr23&utm_medium=email&_hsmi=272117798&_hsenc=p2ANqtz--o9C5ShS9SgggreCu2NAZn7HJ7i_4PQXdc51H0VV3IhtA4TIo3DtqLEkLutLVkvtIm18yBB0c8qvDImUMnFz1y7xkjZQ&utm_content=272117798&utm_source=hs_automation
Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(22)00291-2/fulltext?dgcid=hubspot_email_jcr23_laninf&utm_campaign=jcr23&utm_medium=email&_hsmi=272117798&_hsenc=p2ANqtz-8hzvgopoVdXWZ4O9m5KkMJKSMpSoVCa2bbtwg6kd5ZdlAPG449JscN6BlpywM2SIqro5QOu1dLJgh3yrsap7ujtS7ifg&utm_content=272117798&utm_source=hs_automation
Metabolic effects and safety of dolutegravir in pregnancy
https://www.thelancet.com/journals/lanhiv/home?dgcid=hubspot_email_jcr23_lanhiv&utm_campaign=jcr23&utm_medium=email&_hsmi=272342433&_hsenc=p2ANqtz-89QYlo21nEsrpcFLJxFTEzOQHc3KN4NB4QECu6ieBFpAnVwO_ZaKVdSsKizRKPGIUjdL9RtPY6Np_1J0MUor1MJjoG7Q&utm_content=272342433&utm_source=hs_automation
Life expectancy after 2015 of adults with HIV on long-term antiretroviral therapy in Europe and North America: a collaborative analysis of cohort studies
Open Access
https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(23)00028-0/fulltext?dgcid=hubspot_email_jcr23_lanhiv&utm_campaign=jcr23&utm_medium=email&_hsmi=272342433&_hsenc=p2ANqtz--8jx61RLepMC-y-DHZIvZj8UbMm4HwDMiH10ls-yKBYny-zr0sHXdAW4KXJh7hVOSc1apntQVkR72BOYesCimquS-bUA&utm_content=272342433&utm_source=hs_automation
Trends in HIV prevalence, incidence, and progress towards the UNAIDS 95-95-95 targets in Malawi among individuals aged 15–64 years: population-based HIV impact assessments, 2015−16 and 2020−21
https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(23)00144-3/fulltext?dgcid=hubspot_email_jcr23_lanhiv&utm_campaign=jcr23&utm_medium=email&_hsmi=272342433&_hsenc=p2ANqtz-9Mc9FMfwaJBKmS4eb4Fs9akQvmKqTDg00bTTZ_jV8AGhsi0Z-6jBGXkTgwpxt9b0ncVPKdnhUA7HAcBXmQIrtcej0qvA&utm_content=272342433&utm_source=hs_automation
Trends in HIV testing, the treatment cascade, and HIV incidence among men who have sex with men in Africa: a systematic review and meta-analysis
Open Access
https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(23)00111-X/fulltext?dgcid=hubspot_email_jcr23_lanhiv&utm_campaign=jcr23&utm_medium=email&_hsmi=272342433&_hsenc=p2ANqtz-9fj55ddFCOIZ6EyVZBkr7K0iLrGfnRv9uIV1A4JIWJs-6HcWZkrs_BRgNWpWurP2ejvyMlfs5ZsLOt8paqPixXMZHP7g&utm_content=272342433&utm_source=hs_automation
HIV infection and engagement in the care continuum among migrants and refugees from Venezuela in Colombia: a cross-sectional, biobehavioural survey
https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(23)00085-1/fulltext?dgcid=hubspot_email_jcr23_lanhiv&utm_campaign=jcr23&utm_medium=email&_hsmi=272342433&_hsenc=p2ANqtz-8UpHExRhqq6vGaloyZkaecfs34mb95FU9_eUgefNOje1Zb-OdTZ3p4rxvYpq6I6QS15JuLOlG4keWdUm3l4W7DlLBccw&utm_content=272342433&utm_source=hs_automation
HIV incidence and mortality in transgender women in the eastern and southern USA: a multisite cohort study
https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(23)00008-5/fulltext?dgcid=hubspot_email_jcr23_lanhiv&utm_campaign=jcr23&utm_medium=email&_hsmi=272342433&_hsenc=p2ANqtz-_SnSUvbqaHpgwy58IPBE3hLadBPDk9xd9B5cn4-70-MnvD73o_n93div_Nq1Q4-j-hS-hQlz22pPe8S8oBrw86NiTizg&utm_content=272342433&utm_source=hs_automation
The optimal healthy ranges of thyroid function defined by the risk of cardiovascular disease and mortality: systematic review and individual participant data meta-analysis Xu et al.
https://www.thelancet.com/journals/landia/home?dgcid=hubspot_email_jcr23_landia&utm_campaign=jcr23&utm_medium=email&_hsmi=272333870&_hsenc=p2ANqtz-8cJnNgVSq6DvUFnaqu4SANrVycngb8xnmSCJFGR95ZiQbUdk5hTfJA8iT78oM8bjdop-Wt6oUAwoqPcYORm7fI2Y9LNQ&utm_content=272333870&utm_source=hs_automation
Oct 2023
Volume 11Number 10p707-782, e12
Many years of life lost to young-onset type 2 diabetes
Bruce B Duncan,Maria Inês Schmidt
https://www.thelancet.com/journals/landia/issue/current
Ethnicity-specific BMI cutoffs for obesity based on type 2 diabetes risk in England: a population-based cohort study
Open Access
https://www.thelancet.com/journals/landia/article/PIIS2213-8587(21)00088-7/fulltext?dgcid=hubspot_email_jcr23_landia&utm_campaign=jcr23&utm_medium=email&_hsmi=272333870&_hsenc=p2ANqtz-_AC-4KVO4MxyTWx8z-tMeEbsziMPDeePC0ZD2T1sSaYyoTw6TzK5lk1sh6o4USph6BIE6K03Hno-LPHNMBU2ntGs6u0g&utm_content=272333870&utm_source=hs_automation
Risks and burdens of incident diabetes in long COVID: a cohort study
https://www.thelancet.com/journals/landia/article/PIIS2213-8587(22)00044-4/fulltext?dgcid=hubspot_email_jcr23_landia&utm_campaign=jcr23&utm_medium=email&_hsmi=272333870&_hsenc=p2ANqtz--qWuhr9LwCkyla37FSuAtE5Kq0wxkitLs0JtBAvlUnoXVUkCvb2iDMDUHSt7hZ6HjQL4858yC4qwOTTVL33uclE7Kr_w&utm_content=272333870&utm_source=hs_automation
Global incidence, prevalence, and mortality of type 1 diabetes in 2021 with projection to 2040: a modelling study
https://www.thelancet.com/journals/landia/article/PIIS2213-8587(22)00218-2/fulltext?dgcid=hubspot_email_jcr23_landia&utm_campaign=jcr23&utm_medium=email&_hsmi=272333870&_hsenc=p2ANqtz-_cBpWL2cICiHLRVIZ4KZz2TXKPf9T0YwCbfdxf6VbvPnNxKXN_aRBdJI5xqdzJ8imx1STt6dxpekAwVN6EDqdYTdtspg&utm_content=272333870&utm_source=hs_automation
Thyroid cancer incidence trends by histology in 25 countries: a population-based study
https://www.thelancet.com/journals/landia/article/PIIS2213-8587(21)00027-9/fulltext?dgcid=hubspot_email_jcr23_landia&utm_campaign=jcr23&utm_medium=email&_hsmi=272333870&_hsenc=p2ANqtz-9DW8Ck40F3iAJ1TqF2fsxPG8p0BTjfftK7jUdK-2ygGeNi-JGnQW7Kb8hjVp5fSW3TwhtBUiWuTxrbMxOJAQwyuSv9oQ&utm_content=272333870&utm_source=hs_automation
Towards unified and impactful policies to reduce ultra-processed food consumption and promote healthier eating
https://www.thelancet.com/journals/landia/article/PIIS2213-8587(21)00078-4/fulltext?dgcid=hubspot_email_jcr23_landia&utm_campaign=jcr23&utm_medium=email&_hsmi=272333870&_hsenc=p2ANqtz-_-9Es7X0UXlfneGFd9_yW8P2np3rEF9XyBjH6qmLzRmZGstGUdyav6hCnWoqcfQr92M3CoBN5iw-EagLPbrVFDTgrTHw&utm_content=272333870&utm_source=hs_automation
Impact of low disease activity, remission, and complete remission on flares following tapering of corticosteroids and immunosuppressive therapy in patients with systemic lupus erythematous: a multinational cohort study Cho et al.
https://www.thelancet.com/journals/lanrhe/home?dgcid=hubspot_email_jcr23_lanrhe&utm_campaign=jcr23&utm_medium=email&_hsmi=272456923&_hsenc=p2ANqtz-8SSQ5CH2sBdvdEWgNNB6hc1LZenV9g4RUZDZKExExqJWs1HsWEDW-Gsz0cDpqUB72ZPCspzvqPFjH2Bncua_GUj2qlrg&utm_content=272456923&utm_source=hs_automation
Oct 2023
Volume 5Number 10e565-e638
Burden of rheumatoid arthritis and forecasted prevalence to 2050
Chak Sing Lau
https://www.thelancet.com/journals/lanrhe/issue/current
Improving outcome after paediatric concussion: challenges and possibilities Beauchamp et al.
Improving outcome after paediatric concussion: challenges and possibilities
Beauchamp et al.
https://www.thelancet.com/journals/lanchi/home?dgcid=hubspot_email_jcr23_lanchi&utm_campaign=jcr23&utm_medium=email&_hsmi=272332282&_hsenc=p2ANqtz-9nmLcGnBcYRURALYV03brMe1mXcYnGAXL3oyxc-GAS-pj9zbagbv6ZdJ5NTtBRmFG20UnlQzJqmXSugz-5_y2HoKV3og&utm_content=272332282&utm_source=hs_automation
Oct 2023
Volume 7Number 10p671-746
Social adolescents, social media, and social emotional development
Keneisha Sinclair-McBride,Michael Rich
https://www.thelancet.com/journals/lanchi/issue/current
Advancing the rights of street and working children
https://www.thelancet.com/journals/lanchi/article/PIIS2352-4642(23)00058-5/fulltext?dgcid=hubspot_email_jcr23_lanchi&utm_campaign=jcr23&utm_medium=email&_hsmi=272332282&_hsenc=p2ANqtz-9QuZ76qiOToIfThNXuZxrphO0e8szyOPkrGblUaEyT8RPYF093BpLUGRWoGGnhhNUzt9gE24E3cpSeGJXQSXHiL1xnHg&utm_content=272332282&utm_source=hs_automation
Assessment of infant position and timing of stylet removal to improve lumbar puncture success in neonates (NeoCLEAR): an open-label, 2 × 2 factorial, randomised, controlled trial
Open Access
https://www.thelancet.com/journals/lanchi/article/PIIS2352-4642(22)00343-1/fulltext?dgcid=hubspot_email_jcr23_lanchi&utm_campaign=jcr23&utm_medium=email&_hsmi=272332282&_hsenc=p2ANqtz-_q_ybPaLq9XhMjbBZA6UVwAfuobYwGc34eebFP2AY8jyR6Mvx6ou9k8xKhr-NGfaCx-qoJml8jY5XaQn74diMPk6g4Yg&utm_content=272332282&utm_source=hs_automation
Mortality after hospital discharge among children younger than 5 years admitted with suspected sepsis in Uganda: a prospective, multisite, observational cohort study
https://www.thelancet.com/journals/lanchi/article/PIIS2352-4642(23)00052-4/fulltext?dgcid=hubspot_email_jcr23_lanchi&utm_campaign=jcr23&utm_medium=email&_hsmi=272332282&_hsenc=p2ANqtz-8x9vhD4MJx2764t4kBLbY8ZDdVddHlCHfkEiPBSgcGDFXX1fHjZSZAu16n56fwBGRftxbCrMpkEPCKxftk70XnIX9-Xw&utm_content=272332282&utm_source=hs_automation
Temporal trends in eating disorder and self-harm incidence rates among adolescents and young adults in the UK in the 2 years since onset of the COVID-19 pandemic: a population-based study
Open Access
https://www.thelancet.com/journals/lanchi/article/PIIS2352-4642(23)00126-8/fulltext?dgcid=hubspot_email_jcr23_lanchi&utm_campaign=jcr23&utm_medium=email&_hsmi=272332282&_hsenc=p2ANqtz--8l4FB3Z9hUXuOIPuUHXgnyow6CXrV-lMQYNNCgMqFWxbzbu1zQwDmvDKYloyvVlSlK3gFwQTBLrCkxV0T-5_GeyeR-w&utm_content=272332282&utm_source=hs_automation
Supporting every school to become a foundation for healthy lives
https://www.thelancet.com/journals/lanchi/article/PIIS2352-4642(20)30316-3/fulltext?dgcid=hubspot_email_jcr23_lanchi&utm_campaign=jcr23&utm_medium=email&_hsmi=272332282&_hsenc=p2ANqtz-8iipmJ2ScLo1ooQPUerXHllYy9z-TRlO10o4YHQWk7d7_1pxl8AmwM29MgdgKhwUEcTPgv2YDa9N4RB_nNPRsd6SnWCA&utm_content=272332282&utm_source=hs_automation
"The worlds of early intervention psychiatry and personality disorder research need to work together."
https://www.thelancet.com/journals/lanpsy/home?dgcid=hubspot_email_jcr23_lanpsy&utm_campaign=jcr23&utm_medium=email&_hsmi=272112761&_hsenc=p2ANqtz-9D4cfFB_AE9rdiZXzAkDOgy0ZsJ6arH4QOuI_3mrfYzcocOBRBLgjCN3rltwm8vbmWb4rLc9iPVLHmRoxeMufPKIakjw&utm_content=272112761&utm_source=hs_automation
Oct 2023
Volume 10Number 10p733-816, e26-e27
Complex PTSD as mediator of psychosis after childhood trauma
Nynke A Groenewold
https://www.thelancet.com/journals/lanpsy/issue/current
Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study
https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(16)30065-7/fulltext?dgcid=hubspot_email_jcr23_lanpsy&utm_campaign=jcr23&utm_medium=email&_hsmi=272112761&_hsenc=p2ANqtz-_kET3q-mDnJIfytp9vlwFtVjWU4dToppCDWsewWjcLLPkRV2otTFBoYhSBUreZX7ZQFz3Hxi_UPDeBLWGqjaPEdfO_OA&utm_content=272112761&utm_source=hs_automation
Maintenance ketamine treatment for depression: a systematic review of efficacy, safety, and tolerability
https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(22)00317-0/fulltext?dgcid=hubspot_email_jcr23_lanpsy&utm_campaign=jcr23&utm_medium=email&_hsmi=272112761&_hsenc=p2ANqtz-88Nzrncy8UQWQ8iFz_nE-RF0RjYgu54JhSNoJHxolGA5kE7_-WYUdJmJ8UTVcShh15GGFmkLR7zNB0W1XiSRq-NMTKaQ&utm_content=272112761&utm_source=hs_automation
The Lancet Psychiatry Commission on intimate partner violence and mental health: advancing mental health services, research, and policy
https://www.thelancet.com/commissions/intimate-partner-violence?dgcid=hubspot_email_jcr23_lanpsy&utm_campaign=jcr23&utm_medium=email&_hsmi=272112761&_hsenc=p2ANqtz--ZShSJ13rPWVaCiR5zrnLXWcxfNKobDYZ2IrAlnd9Oxd_S3lqOZ3o38glol67F6KB3-CqJd5TDzMCgHcs2Zpp49gZqZQ&utm_content=272112761&utm_source=hs_automation
Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients
https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(22)00260-7/fulltext?dgcid=hubspot_email_jcr23_lanpsy&utm_campaign=jcr23&utm_medium=email&_hsmi=272112761&_hsenc=p2ANqtz-_K1B9nsDdqHUm4tsQwv8O7tdvA9WUMLI3WPE71aratISU-O6RHxB_FdgfryYIPNBE3F7faSqLWm1LcMhxNGUqDWvtkpQ&utm_content=272112761&utm_source=hs_automation
Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study Razavi-Shearer et al.
Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study
Razavi-Shearer et al.
Oct 2023
Volume 8Number 10p861-954
Food as a global health and social priority
The Lancet Gastroenterology & Hepatology
https://www.thelancet.com/journals/langas/issue/current
a.The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis
https://www.thelancet.com/journals/langas/article/PIIS2468-1253(22)00165-0/fulltext?dgcid=hubspot_email_jcr23_langas&utm_campaign=jcr23&utm_medium=email&_hsmi=272336523&_hsenc=p2ANqtz-8e51IPnqk9yAttwB3VqrE3-Oum7iKZr6g6yKml75iU_aLsyYbFQHFGlUdj6Agj5FhuvmPQH2fQJMVKfvUNjl6fE1GU-w&utm_content=272336523&utm_source=hs_automation
b.Rifaximin-α for liver fibrosis in patients with alcohol-related liver disease (GALA-RIF): a randomised, double-blind, placebo-controlled, phase 2 trial
Open Access
https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00010-9/fulltext?dgcid=hubspot_email_jcr23_langas&utm_campaign=jcr23&utm_medium=email&_hsmi=272336523&_hsenc=p2ANqtz-_IjcYW2kN57txThqkPq6fMBjeJSkpJvTAvuxyaG-XEc_iaXXySe6A7NhRFE_nvpxxuawB_qFk3XfzeW8cycn1Fx_xP9A&utm_content=272336523&utm_source=hs_automation
c.Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study
https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00197-8/fulltext?dgcid=hubspot_email_jcr23_langas&utm_campaign=jcr23&utm_medium=email&_hsmi=272336523&_hsenc=p2ANqtz-97Z3py5_Ez-NzrRheFeqHeS85atIr0RmZfhNGTV2gGX_wd9h6XNW9qqyoFdMjIKkOshLcyXdGMqBGJwZ9eJacgqo_GEg&utm_content=272336523&utm_source=hs_automation
d.Guselkumab plus golimumab combination therapy versus guselkumab or golimumab monotherapy in patients with ulcerative colitis (VEGA): a randomised, double-blind, controlled, phase 2, proof-of-concept trial
https://www.thelancet.com/journals/langas/article/PIIS2468-1253(22)00427-7/fulltext?dgcid=hubspot_email_jcr23_langas&utm_campaign=jcr23&utm_medium=email&_hsmi=272336523&_hsenc=p2ANqtz-_bSY-_7rK0WzuP3zgVpy_qcbOA1ErB0gU3gBdLRGClgQ8_AVaUeKC-5op1D06NlPj05AE6t1hjY-kmVGyGrSZuSmzvFA&utm_content=272336523&utm_source=hs_automation
e.Withdrawal of infliximab or concomitant immunosuppressant therapy in patients with Crohn's disease on combination therapy (SPARE): a multicentre, open-label, randomised controlled trialThe prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis
https://www.thelancet.com/journals/langas/article/PIIS2468-1253(22)00385-5/fulltext?dgcid=hubspot_email_jcr23_langas&utm_campaign=jcr23&utm_medium=email&_hsmi=272336523&_hsenc=p2ANqtz-9GV6alyyalvL-YxWV2sTYDbXRU8g0NItNaESfTvtyYfx3PFXcE8kmM1bGXVDRBWwd6YkMgMluG9HTr_FKZ99YcK-J7Uw&utm_content=272336523&utm_source=hs_automation
Safety and efficacy of tamoxifen in boys with Duchenne muscular dystrophy (TAMDMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial Henzi et al.
https://www.thelancet.com/journals/laneur/home?dgcid=hubspot_email_jcr23_laneur&utm_medium=email&_hsmi=272344443&_hsenc=p2ANqtz-9QvDWGlaRcEyTr4RC0QdavddK_O8LMBn0OXmxqDgbePexnMZV630caDKWaJP8Hc80-C5_0n-EnxPJBKmVdCujf-g9GPw&utm_content=272344443&utm_source=hs_automation
Oct 2023
Volume 22Number 10p871-970, e11
Sustainable development demands brain health
The Lancet Neurology
https://www.thelancet.com/journals/laneur/issue/current
The 2022 South America report of The Lancet Countdown on health and climate change: trust the science. Now that we know, we must act
https://www.thelancet.com/journals/lanam/issue/current
1.Vaccination reduces need for emergency care in breakthrough COVID-19 infections: A multicenter cohort study
https://www.thelancet.com/journals/lanam/article/PIIS2667-193X(21)00061-2/fulltext?dgcid=hubspot_email_jcr23_lanam&utm_campaign=jcr23&utm_medium=email&_hsmi=272453185&_hsenc=p2ANqtz-8Et5Yu-y-sXv1FXpfhLyf8fARjzhsI5PSeLmEhHmpgvyQ71RgOrJvR8xxLOjaWmNzDjUE6ChS2cYMm9alyRh9Nn4kAng&utm_content=272453185&utm_source=hs_automation
2.A policy study on front–of–pack nutrition labeling in the Americas: emerging developments and outcomes
https://www.thelancet.com/journals/lanam/article/PIIS2667-193X(22)00217-4/fulltext?dgcid=hubspot_email_jcr23_lanam&utm_campaign=jcr23&utm_medium=email&_hsmi=272453185&_hsenc=p2ANqtz-_ihftG2H4N_EhVtNJrRPRl8AVpQBLnr9_-uVAttblMTTf6x00pY9_fTcorsaOW4FWqjqzyQ3Hrqe_ulnicA3QFr_JDNw&utm_content=272453185&utm_source=hs_automation
3.Classification of Alzheimer's disease and frontotemporal dementia using routine clinical and cognitive measures across multicentric underrepresented samples: a cross sectional observational study
https://www.thelancet.com/journals/lanam/article/PIIS2667-193X(22)00204-6/fulltext?dgcid=hubspot_email_jcr23_lanam&utm_campaign=jcr23&utm_medium=email&_hsmi=272453185&_hsenc=p2ANqtz-9mlJmcHpLlUGQ3kkW2BZqtOEMn3N6zkOWIa9l6W2XfmopU96rQFPrc2xiMedzx2mUouuKu8hEKDMf26sy11Da6oCSetg&utm_content=272453185&utm_source=hs_automation
4.Safety and effectiveness of self-managed medication abortion provided using online telemedicine in the United States: A population based study
https://www.thelancet.com/journals/lanam/article/PIIS2667-193X(22)00017-5/fulltext?dgcid=hubspot_email_jcr23_lanam&utm_campaign=jcr23&utm_medium=email&_hsmi=272453185&_hsenc=p2ANqtz-8NwJbqmBPDQuQahImva9PLzHRI-7qFE9LlCmwBMn2e80iF7yxuojARzUZx3bZw5Q8u3CvM52MIqSeSqr2MO4aqRs9lNA&utm_content=272453185&utm_source=hs_automation
5.Breastfeeding and post-perinatal infant deaths in the United States, A national prospective cohort analysis
https://www.thelancet.com/journals/lanam/article/PIIS2667-193X(21)00090-9/fulltext?dgcid=hubspot_email_jcr23_lanam&utm_campaign=jcr23&utm_medium=email&_hsmi=272453185&_hsenc=p2ANqtz-8EcKuIokbrQp3sX6aDFMkws-pyDcVKMmmVQpedix2WBTUcc4VWX6V3EHtWJE61G-AIq27BvcdDXo-PEnTHcl2On5C1PQ&utm_content=272453185&utm_source=hs_automation
6.The 2022 South America report of The Lancet Countdown on health and climate change: trust the science. Now that we know, we must act
https://www.thelancet.com/journals/lanam/article/PIIS2667-193X(23)00044-3/fulltext?dgcid=hubspot_email_jcr23_lanam&utm_campaign=jcr23&utm_medium=email&_hsmi=272453185&_hsenc=p2ANqtz-_lF_qQLbgOOXZ0gJNn1Cw9eMrcBiebZ22H1sDOcOIFaPhH3GkHYLqgC6eGadnzRT5lhbcKTdGMufXLLJqEWAKZcvQpdA&utm_content=272453185&utm_source=hs_automation
sábado, 30 de septiembre de 2023
Advances in breast cancer research shared with NIH and the world
https://factor.niehs.nih.gov/2023/10/feature/breast-cancer-sister-study-advances-20-years?utm_medium=email&utm_source=govdelivery
As Sister Study turns 20, NIEHS lead researcher highlights study’s major findings at prestigious NIH lecture.
Tainted Arthritis | Pain Products: Hidden drug ingredients identified in products marketed for pain and arthritis
https://www.fda.gov/drugs/medication-health-fraud/tainted-arthritis-pain-products?utm_medium=email&utm_source=govdelivery
Kuka Flex Forte contains hidden drug ingredient
https://www.fda.gov/drugs/medication-health-fraud/kuka-flex-forte-contains-hidden-drug-ingredient?utm_medium=email&utm_source=govdelivery
Reumo Flex contains hidden drug ingredient
https://www.fda.gov/drugs/medication-health-fraud/reumo-flex-contains-hidden-drug-ingredient?utm_medium=email&utm_source=govdelivery
Article Spotlights an Often-Neglected Part of the Body Director’s Page Helene M. Langevin, M.D.
https://www.nccih.nih.gov/about/offices/od/director/past-messages/article-spotlights-an-often-neglected-part-of-the-body?nav=govd
I was so pleased to speak recently with The New York Times reporter, Danielle Friedman, for her recent story on fascia, “The Tissue That Connects Our Muscles May Be a Key to Better Health.” The role of fascia in how our bodies function and the impact on our health is a topic that hasn’t gotten enough attention, but that is beginning to change, and it’s encouraging to have a thoughtful discussion on this subject.
As Ms. Friedman explained, fascia is “the tough, flexible tissue that surrounds and connects muscles, bones, and organs like cling wrap.” I’m proud of the National Center for Complementary and Integrative Health’s work to advance research on this significant yet understudied part of our bodies. Our efforts are aimed at answering questions on how the health of fascia relates to overall health and wellness, physical performance, and its relationship to chronic pain, which affects about one in five Americans.
viernes, 29 de septiembre de 2023
Suscribirse a:
Entradas (Atom)